{"schema_version":"secwatch.filing_event.v1","accession":"0000019584-25-000004","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2025-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.153716+00:00","generated_at":"2026-05-17T02:00:40.747016+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Chemed Q3 GAAP EPS falls 10.8% to $4.46; adjusted EPS down 6.6% to $5.27","bullets":["Consolidated revenue $624.9M (+3.1% YoY); VITAS revenue $407.7M (+4.2%), Roto-Rooter $217.2M (+1.1%).","VITAS ADC 22,327 (+2.5%); admissions up 5.6%; Medicare Cap accrual $6.1M vs $2.2M prior year.","Roto-Rooter adjusted EBITDA $49.4M (-12.4%); margin 22.7% vs 26.2% prior year.","Chemed: $129.8M cash, no debt; repurchased 407,500 shares for $180.8M during quarter.","Reiterates FY2025 adjusted EPS guidance $22.00-$22.30, assuming no Florida Medicare Cap."],"urls":{"canonical":"https://secwatch.observer/filing/0000019584-25-000004","json":"https://secwatch.observer/filing/0000019584-25-000004.json","markdown":"https://secwatch.observer/filing/0000019584-25-000004.md","text":"https://secwatch.observer/filing/0000019584-25-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000001958425000004/0000019584-25-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000001958425000004/che-20251028x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:00:40.747016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}